Seat­tle biotech clos­es $18M Se­ries B — and ac­quires a com­pa­ny; An­oth­er George Church alum launch­es up­start

Seat­tle biotech Cyrus Biotech­nol­o­gy an­nounced this morn­ing that it closed an $18 mil­lion Se­ries B — and land­ed an ac­qui­si­tion to boot.

The biotech, which has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER